LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Unraveling the complexity of basal-like breast cancer.

    Marotta, Lauren L C / Polyak, Kornelia

    Oncotarget

    2011  Volume 2, Issue 8, Page(s) 588–589

    MeSH term(s) Animals ; Breast Neoplasms/drug therapy ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Molecular Targeted Therapy ; Prognosis ; Signal Transduction
    Language English
    Publishing date 2011-08-29
    Publishing country United States
    Document type Editorial
    ZDB-ID 2560162-3
    ISSN 1949-2553 ; 1949-2553
    ISSN (online) 1949-2553
    ISSN 1949-2553
    DOI 10.18632/oncotarget.314
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A Web-Based Intervention to Increase Smokers' Intentions to Participate in a Cessation Study Offered at the Point of Lung Screening: Factorial Randomized Trial.

    Neil, Jordan M / Chang, Yuchiao / Goshe, Brett / Rigotti, Nancy / Gonzalez, Irina / Hawari, Saif / Ballini, Lauren / Haas, Jennifer S / Marotta, Caylin / Wint, Amy / Harris, Kim / Crute, Sydney / Flores, Efren / Park, Elyse R

    JMIR formative research

    2021  Volume 5, Issue 6, Page(s) e28952

    Abstract: Background: Screen ASSIST is a cessation trial offered to current smokers at the point of lung cancer screening. Because of the unique position of promoting a prevention behavior (smoking cessation) within the context of a detection behavior (lung ... ...

    Abstract Background: Screen ASSIST is a cessation trial offered to current smokers at the point of lung cancer screening. Because of the unique position of promoting a prevention behavior (smoking cessation) within the context of a detection behavior (lung cancer screening), this study employed prospect theory to design and formatively evaluate a targeted recruitment video prior to trial launch.
    Objective: The aim of this study was to identify which message frames were most effective at promoting intent to participate in a smoking cessation study.
    Methods: Participants were recruited from a proprietary opt-in online panel company and randomized to a 2 (benefits of quitting vs risks of continuing to smoke at the time of lung screening; BvR) × 2 (gains of participating vs losses of not participating in a cessation study; GvL) message design experiment (N=314). The primary outcome was self-assessed intent to participate in a smoking cessation study. Message effectiveness and lung cancer risk perception measures were also collected. Analysis of variance examined the main effect of the 2 message factors and a least absolute shrinkage and selection operator (LASSO) approach identified predictors of intent to participate in a multivariable model. A mediation analysis was conducted to determine the direct and indirect effects of message factors on intent to participate in a cessation study.
    Results: A total of 296 participants completed the intervention. There were no significant differences in intent to participate in a smoking cessation study between message frames (P=.12 and P=.61). In the multivariable model, quit importance (P<.001), perceived message relevance (P<.001), and affective risk response (ie, worry about developing lung cancer; P<.001) were significant predictors of intent to participate. The benefits of quitting frame significantly increased affective risk response (Mean
    Conclusions: This study provides theoretical and practical guidance on how to design and evaluate proactive recruitment messages for a cessation trial. Based on our findings, we conclude that heavy smokers are more responsive to recruitment messages that frame the benefits of quitting as it increased affective risk response, which predicted greater intention to participate in a smoking cessation study.
    Language English
    Publishing date 2021-06-30
    Publishing country Canada
    Document type Journal Article
    ISSN 2561-326X
    ISSN (online) 2561-326X
    DOI 10.2196/28952
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Nutritional studies on production of antibacterial activity by the zebra mussel antagonist, Pseudomonas fluorescens CL0145A.

    Polanski-Cordovano, Grace / Romano, Lea / Marotta, Lauren L C / Jacob, Sarena / Soo Hoo, Jennifer / Tartaglia, Elena / Asokan, Deepa / Kar, Simkie / Demain, Arnold L

    Journal of microbiology and biotechnology

    2013  Volume 23, Issue 5, Page(s) 656–660

    Abstract: Pseudomonas fluorescens strain CL0145A was discovered at the New York State Museum Field Research Laboratory as an effective agent against the environmentally destructive zebra mussel, which has contaminated US waters. Dried cells of the microbe are ... ...

    Abstract Pseudomonas fluorescens strain CL0145A was discovered at the New York State Museum Field Research Laboratory as an effective agent against the environmentally destructive zebra mussel, which has contaminated US waters. Dried cells of the microbe are being commercialized as an environmentally friendly solution to the problem. We found that antibiotic activity against the Gram-positive bacterium Bacillus subtilis is produced and excreted by this strain. We have carried out studies to optimize production of the antibiotic. Studies were begun in a complex corn meal medium. Activity was found in both cells and culture supernates and was maximal after one day of fermentation. Static fermentation conditions were found to be superior to shaken culture. Production of extracellular antibiotic in complex medium was found to be dependent on the content of sucrose and enzymehydrolyzed casein. Indeed, production was greater in sucrose plus enzyme-hydrolyzed casein than in the complex medium. Of a large number of carbon sources studied as improvements over sucrose, the best was glycerol. An examination of nitrogen sources showed that production was improved by replacement of enzymehydrolyzed casein with soy hydrolysates. Production in the simple glycerol-Hy-Soy medium was not improved by addition of an inorganic salt mixture or by complex nitrogen sources, with the exception of malt extract. In an attempt to keep the medium more defined, we studied the effect of amino acids and vitamins as replacements for malt extract. Of 21 amino acids and 7 vitamins, we found tryptophan, glutamine, biotin, and riboflavin to be stimulatory. The final medium contained glycerol, Hy- Soy, tryptophan, glutamine, biotin, and riboflavin.
    MeSH term(s) Amino Acids/metabolism ; Animals ; Anti-Bacterial Agents/metabolism ; Anti-Bacterial Agents/pharmacology ; Carbon/metabolism ; Culture Media/chemistry ; Culture Media/metabolism ; Dreissena/chemistry ; Dreissena/metabolism ; Nitrogen/metabolism ; Pseudomonas fluorescens/drug effects
    Chemical Substances Amino Acids ; Anti-Bacterial Agents ; Culture Media ; Carbon (7440-44-0) ; Nitrogen (N762921K75)
    Language English
    Publishing date 2013-02-14
    Publishing country Korea (South)
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1738-8872
    ISSN (online) 1738-8872
    DOI 10.4014/jmb.1211.11035
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.

    Marotta, Lauren L C / Almendro, Vanessa / Marusyk, Andriy / Shipitsin, Michail / Schemme, Janina / Walker, Sarah R / Bloushtain-Qimron, Noga / Kim, Jessica J / Choudhury, Sibgat A / Maruyama, Reo / Wu, Zhenhua / Gönen, Mithat / Mulvey, Laura A / Bessarabova, Marina O / Huh, Sung Jin / Silver, Serena J / Kim, So Young / Park, So Yeon / Lee, Hee Eun /
    Anderson, Karen S / Richardson, Andrea L / Nikolskaya, Tatiana / Nikolsky, Yuri / Liu, X Shirley / Root, David E / Hahn, William C / Frank, David A / Polyak, Kornelia

    The Journal of clinical investigation

    2011  Volume 121, Issue 7, Page(s) 2723–2735

    Abstract: Intratumor heterogeneity is a major clinical problem because tumor cell subtypes display variable sensitivity to therapeutics and may play different roles in progression. We previously characterized 2 cell populations in human breast tumors with distinct ...

    Abstract Intratumor heterogeneity is a major clinical problem because tumor cell subtypes display variable sensitivity to therapeutics and may play different roles in progression. We previously characterized 2 cell populations in human breast tumors with distinct properties: CD44+CD24- cells that have stem cell-like characteristics, and CD44-CD24+ cells that resemble more differentiated breast cancer cells. Here we identified 15 genes required for cell growth or proliferation in CD44+CD24- human breast cancer cells in a large-scale loss-of-function screen and found that inhibition of several of these (IL6, PTGIS, HAS1, CXCL3, and PFKFB3) reduced Stat3 activation. We found that the IL-6/JAK2/Stat3 pathway was preferentially active in CD44+CD24- breast cancer cells compared with other tumor cell types, and inhibition of JAK2 decreased their number and blocked growth of xenografts. Our results highlight the differences between distinct breast cancer cell types and identify targets such as JAK2 and Stat3 that may lead to more specific and effective breast cancer therapies.
    MeSH term(s) Animals ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; CD24 Antigen/genetics ; CD24 Antigen/metabolism ; Cell Line, Tumor ; Female ; Gene Expression Profiling ; Humans ; Hyaluronan Receptors/genetics ; Hyaluronan Receptors/metabolism ; Interleukin-6/genetics ; Interleukin-6/metabolism ; Janus Kinase 2/antagonists & inhibitors ; Janus Kinase 2/genetics ; Janus Kinase 2/metabolism ; Mice ; RNA, Small Interfering/genetics ; RNA, Small Interfering/metabolism ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/metabolism ; Signal Transduction/physiology ; Stem Cells/cytology ; Stem Cells/physiology ; Transplantation, Heterologous
    Chemical Substances CD24 Antigen ; Hyaluronan Receptors ; Interleukin-6 ; RNA, Small Interfering ; STAT3 Transcription Factor ; STAT3 protein, human ; Janus Kinase 2 (EC 2.7.10.2)
    Language English
    Publishing date 2011-06-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI44745
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.

    Peffault de Latour, Régis / Kulasekararaj, Austin / Iacobelli, Simona / Terwel, Sofie R / Cook, Riley / Griffin, Morag / Halkes, Constantijn J M / Recher, Christian / Barraco, Fiorenza / Forcade, Edouard / Vallejo, Juan-Carlos / Drexler, Beatrice / Mear, Jean-Baptiste / Smith, Alexander E / Angelucci, Emanuele / Raymakers, Reinier A P / de Groot, Marco R / Daguindau, Etienne / Nur, Erfan /
    Barcellini, Wilma / Russell, Nigel H / Terriou, Louis / Iori, Anna-Paola / La Rocca, Ursula / Sureda, Anna / Sánchez-Ortega, Isabel / Xicoy, Blanca / Jarque, Isidro / Cavenagh, James / Sicre de Fontbrune, Flore / Marotta, Serena / Munir, Talha / Tjon, Jennifer M L / Tavitian, Suzanne / Praire, Aline / Clement, Laurence / Rabian, Florence / Marano, Luana / Hill, Anita / Palmisani, Elena / Muus, Petra / Cacace, Fabiana / Frieri, Camilla / van Lint, Maria-Teresa / Passweg, Jakob R / Marsh, Judith C W / Socié, Gérard / Mufti, Ghulam J / Dufour, Carlo / Risitano, Antonio M

    The New England journal of medicine

    2022  Volume 386, Issue 1, Page(s) 11–23

    Abstract: Background: A single-group, phase 1-2 study indicated that eltrombopag improved the efficacy of standard immunosuppressive therapy that entailed horse antithymocyte globulin (ATG) plus cyclosporine in patients with severe aplastic anemia.: Methods: ... ...

    Abstract Background: A single-group, phase 1-2 study indicated that eltrombopag improved the efficacy of standard immunosuppressive therapy that entailed horse antithymocyte globulin (ATG) plus cyclosporine in patients with severe aplastic anemia.
    Methods: In this prospective, investigator-led, open-label, multicenter, randomized, phase 3 trial, we compared the efficacy and safety of horse ATG plus cyclosporine with or without eltrombopag as front-line therapy in previously untreated patients with severe aplastic anemia. The primary end point was a hematologic complete response at 3 months.
    Results: Patients were assigned to receive immunosuppressive therapy (Group A, 101 patients) or immunosuppressive therapy plus eltrombopag (Group B, 96 patients). The percentage of patients who had a complete response at 3 months was 10% in Group A and 22% in Group B (odds ratio, 3.2; 95% confidence interval [CI], 1.3 to 7.8; P = 0.01). At 6 months, the overall response rate (the percentage of patients who had a complete or partial response) was 41% in Group A and 68% in Group B. The median times to the first response were 8.8 months (Group A) and 3.0 months (Group B). The incidence of severe adverse events was similar in the two groups. With a median follow-up of 24 months, a karyotypic abnormality that was classified as myelodysplastic syndrome developed in 1 patient (Group A) and 2 patients (Group B); event-free survival was 34% and 46%, respectively. Somatic mutations were detected in 29% (Group A) and 31% (Group Β) of the patients at baseline; these percentages increased to 66% and 55%, respectively, at 6 months, without affecting the hematologic response and 2-year outcome.
    Conclusions: The addition of eltrombopag to standard immunosuppressive therapy improved the rate, rapidity, and strength of hematologic response among previously untreated patients with severe aplastic anemia, without additional toxic effects. (Funded by Novartis and others; RACE ClinicalTrials.gov number, NCT02099747; EudraCT number, 2014-000363-40.).
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anemia, Aplastic/drug therapy ; Anemia, Aplastic/genetics ; Anemia, Aplastic/therapy ; Antilymphocyte Serum/adverse effects ; Antilymphocyte Serum/therapeutic use ; Benzoates/adverse effects ; Benzoates/therapeutic use ; Cyclosporine/adverse effects ; Cyclosporine/therapeutic use ; Drug Therapy, Combination ; Female ; Humans ; Hydrazines/adverse effects ; Hydrazines/therapeutic use ; Immunosuppression Therapy ; Immunosuppressive Agents/adverse effects ; Immunosuppressive Agents/therapeutic use ; Male ; Middle Aged ; Progression-Free Survival ; Prospective Studies ; Pyrazoles/adverse effects ; Pyrazoles/therapeutic use ; Receptors, Thrombopoietin/agonists ; Remission Induction ; Young Adult
    Chemical Substances Antilymphocyte Serum ; Benzoates ; Hydrazines ; Immunosuppressive Agents ; Pyrazoles ; Receptors, Thrombopoietin ; Cyclosporine (83HN0GTJ6D) ; eltrombopag (S56D65XJ9G)
    Language English
    Publishing date 2022-01-07
    Publishing country United States
    Document type Clinical Trial, Phase III ; Comparative Study ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMoa2109965
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus.

    Etminan, Nima / Brown, Robert D / Beseoglu, Kerim / Juvela, Seppo / Raymond, Jean / Morita, Akio / Torner, James C / Derdeyn, Colin P / Raabe, Andreas / Mocco, J / Korja, Miikka / Abdulazim, Amr / Amin-Hanjani, Sepideh / Al-Shahi Salman, Rustam / Barrow, Daniel L / Bederson, Joshua / Bonafe, Alain / Dumont, Aaron S / Fiorella, David J /
    Gruber, Andreas / Hankey, Graeme J / Hasan, David M / Hoh, Brian L / Jabbour, Pascal / Kasuya, Hidetoshi / Kelly, Michael E / Kirkpatrick, Peter J / Knuckey, Neville / Koivisto, Timo / Krings, Timo / Lawton, Michael T / Marotta, Thomas R / Mayer, Stephan A / Mee, Edward / Pereira, Vitor Mendes / Molyneux, Andrew / Morgan, Michael K / Mori, Kentaro / Murayama, Yuichi / Nagahiro, Shinji / Nakayama, Naoki / Niemelä, Mika / Ogilvy, Christopher S / Pierot, Laurent / Rabinstein, Alejandro A / Roos, Yvo B W E M / Rinne, Jaakko / Rosenwasser, Robert H / Ronkainen, Antti / Schaller, Karl / Seifert, Volker / Solomon, Robert A / Spears, Julian / Steiger, Hans-Jakob / Vergouwen, Mervyn D I / Wanke, Isabel / Wermer, Marieke J H / Wong, George K C / Wong, John H / Zipfel, Gregory J / Connolly, E Sander / Steinmetz, Helmuth / Lanzino, Giuseppe / Pasqualin, Alberto / Rüfenacht, Daniel / Vajkoczy, Peter / McDougall, Cameron / Hänggi, Daniel / LeRoux, Peter / Rinkel, Gabriel J E / Macdonald, R Loch

    Neurology

    2015  Volume 85, Issue 10, Page(s) 881–889

    Abstract: Objective: We endeavored to develop an unruptured intracranial aneurysm (UIA) treatment score (UIATS) model that includes and quantifies key factors involved in clinical decision-making in the management of UIAs and to assess agreement for this model ... ...

    Abstract Objective: We endeavored to develop an unruptured intracranial aneurysm (UIA) treatment score (UIATS) model that includes and quantifies key factors involved in clinical decision-making in the management of UIAs and to assess agreement for this model among specialists in UIA management and research.
    Methods: An international multidisciplinary (neurosurgery, neuroradiology, neurology, clinical epidemiology) group of 69 specialists was convened to develop and validate the UIATS model using a Delphi consensus. For internal (39 panel members involved in identification of relevant features) and external validation (30 independent external reviewers), 30 selected UIA cases were used to analyze agreement with UIATS management recommendations based on a 5-point Likert scale (5 indicating strong agreement). Interrater agreement (IRA) was assessed with standardized coefficients of dispersion (vr*) (vr* = 0 indicating excellent agreement and vr* = 1 indicating poor agreement).
    Results: The UIATS accounts for 29 key factors in UIA management. Agreement with UIATS (mean Likert scores) was 4.2 (95% confidence interval [CI] 4.1-4.3) per reviewer for both reviewer cohorts; agreement per case was 4.3 (95% CI 4.1-4.4) for panel members and 4.5 (95% CI 4.3-4.6) for external reviewers (p = 0.017). Mean Likert scores were 4.2 (95% CI 4.1-4.3) for interventional reviewers (n = 56) and 4.1 (95% CI 3.9-4.4) for noninterventional reviewers (n = 12) (p = 0.290). Overall IRA (vr*) for both cohorts was 0.026 (95% CI 0.019-0.033).
    Conclusions: This novel UIA decision guidance study captures an excellent consensus among highly informed individuals on UIA management, irrespective of their underlying specialty. Clinicians can use the UIATS as a comprehensive mechanism for indicating how a large group of specialists might manage an individual patient with a UIA.
    MeSH term(s) Humans ; Internationality ; Interprofessional Relations ; Intracranial Aneurysm/diagnosis ; Intracranial Aneurysm/epidemiology ; Intracranial Aneurysm/therapy ; Patient Care Team/standards ; Severity of Illness Index ; Treatment Outcome
    Keywords covid19
    Language English
    Publishing date 2015-08-14
    Publishing country United States
    Document type Consensus Development Conference ; Journal Article
    ZDB-ID 207147-2
    ISSN 1526-632X ; 0028-3878
    ISSN (online) 1526-632X
    ISSN 0028-3878
    DOI 10.1212/WNL.0000000000001891
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Assessment of neurological manifestations in hospitalized patients with COVID‐19

    Luigetti, M. / Iorio, R. / Bentivoglio, A. R. / Tricoli, L. / Riso, V. / Marotta, J. / Piano, C. / Primiano, G. / Zileri Del Verme, L. / Lo Monaco, M. R. / Calabresi, P. / Abbate, Valeria / Acampora, Nicola / Addolorato, Giovanni / Agostini, Fabiana / Ainora, Maria Elena / Akacha, Karim / Amato, Elena / Andreani, Francesca /
    Andriollo, Gloria / Annetta, Maria Giuseppina / Annicchiarico, Brigida Eleonora / Antonelli, Mariangela / Antonucci, Gabriele / Anzellotti, Gian Marco / Armuzzi, Alessandro / Baldi, Fabiana / Barattucci, Ilaria / Barillaro, Christian / Barone, Fabiana / Bellantone, Rocco Domenico Alfonso / Bellieni, Andrea / Bello, Giuseppe / Benicchi, Andrea / Benvenuto, Francesca / Berardini, Ludovica / Berloco, Filippo / Bernabei, Roberto / Bianchi, Antonio / Biasucci, Daniele Guerino / Biasucci, Luigi Marzio / Bibbò, Stefano / Bini, Alessandra / Bisanti, Alessandra / Biscetti, Federico / Bocci, Maria Grazia / Bonadia, Nicola / Bongiovanni, Filippo / Borghetti, Alberto / Bosco, Giulia / Bosello, Silvia / Bove, Vincenzo / Bramato, Giulia / Brandi, Vincenzo / Bruni, Teresa / Bruno, Carmine / Bruno, Dario / Bungaro, Maria Chiara / Buonomo, Alessandro / Burzo, Livia / Calabrese, Angelo / Calvello, Maria Rosaria / Cambieri, Andrea / Cambise, Chiara / Cammà, Giulia / Candelli, Marcello / Canistro, Gennaro / Cantanale, Antonello / Capalbo, Gennaro / Capaldi, Lorenzo / Capone, Emanuele / Capristo, Esmeralda / Carbone, Luigi / Cardone, Silvia / Carelli, Simone / Carfì, Angelo / Carnicelli, Annamaria / Caruso, Cristiano / Casciaro, Francesco Antonio / Catalano, Lucio / Cauda, Roberto / Cecchini, Andrea Leonardo / Cerrito, Lucia / Cesarano, Melania / Chiarito, Annalisa / Cianci, Rossella / Cicchinelli, Sara / Ciccullo, Arturo / Cicetti, Marta / Ciciarello, Francesca / Cingolani, Antonella / Cipriani, Maria Camilla / Consalvo, Maria Ludovica / Coppola, Gaetano / Corbo, Giuseppe Maria / Corsello, Andrea / Costante, Federico / Costanzi, Matteo / Covino, Marcello / Crupi, Davide / Cutuli, Salvatore Lucio / D'Addio, Stefano / D'Alessandro, Alessia / D'Alfonso, Maria Elena / D'Angelo, Emanuela / D'Aversa, Francesca / Damiano, Fernando / De Berardinis, Gian Maria / De Cunzo, Tommaso / De Gaetano, Donati Katleen / De Luca, Giulio / De Matteis, Giuseppe / De Pascale, Gennaro / De Santis, Paolo / De Siena, Martina / De Vito, Francesco / Del Gatto, Valeria / Del Giacomo, Paola / Del Zompo, Fabio / Dell'Anna, Antonio Maria / Della, Polla Davide / Di Gialleonardo, Luca / Di Giambenedetto, Simona / Di Luca, Roberta / Di Maurizio, Luca / Di Muro, Mariangela / Dusina, Alex / Eleuteri, Davide / Esperide, Alessandra / Fachechi, Daniele / Faliero, Domenico / Falsiroli, Cinzia / Fantoni, Massimo / Fedele, Annalaura / Feliciani, Daniela / Ferrante, Cristina / Ferrone, Giuliano / Festa, Rossano / Fiore, Maria Chiara / Flex, Andrea / Forte, Evelina / Franceschi, Francesco / Francesconi, Alessandra / Franza, Laura / Funaro, Barbara / Fuorlo, Mariella / Fusco, Domenico / Gabrielli, Maurizio / Gaetani, Eleonora / Galletta, Claudia / Gallo, Antonella / Gambassi, Giovanni / Garcovich, Matteo / Gasbarrini, Antonio / Gasparrini, Irene / Gelli, Silvia / Giampietro, Antonella / Gigante, Laura / Giuliano, Gabriele / Giuliano, Giorgia / Giupponi, Bianca / Gremese, Elisa / Grieco, Domenico Luca / Guerrera, Manuel / Guglielmi, Valeria / Guidone, Caterina / Gullì, Antonio / Iaconelli, Amerigo / Iafrati, Aurora / Ianiro, Gianluca / Iaquinta, Angela / Impagnatiello, Michele / Inchingolo, Riccardo / Intini, Enrica / Iorio, Raffaele / Izzi, Immacolata Maria / Jovanovic, Tamara / Kadhim, Cristina / La Macchia, Rosa / La Milia, Daniele Ignazio / Landi, Francesco / Landi, Giovanni / Landi, Rosario / Landolfi, Raffaele / Leo, Massimo / Leone, Paolo Maria / Levantesi, Laura / Liguori, Antonio / Liperoti, Rosa / Lizzio, Marco Maria / Lo Monaco Maria, Rita / Locantore, Pietro / Lombardi, Francesco / Lombardi, Gianmarco / Lopetuso, Loris / Loria, Valentina / Losito, Angela Raffaella / Lucia, Mothanje Barbara Patricia / Macagno, Francesco / Macerola, Noemi / Maggi, Giampaolo / Maiuro, Giuseppe / Mancarella, Francesco / Mangiola, Francesca / Manno, Alberto / Marchesini, Debora / Maresca, Gian Marco / Marrone, Giuseppe / Martis, Ilaria / Martone, Anna Maria / Marzetti, Emanuele / Mattana, Chiara / Matteo, Maria Valeria / Maviglia, Riccardo / Mazzarella, Ada / Memoli, Carmen / Miele, Luca / Migneco, Alessio / Mignini, Irene / Milani, Alessandro / Milardi, Domenico / Montalto, Massimo / Montemurro, Giuliano / Monti, Flavia / Montini, Luca / Morena, Tony Christian / Morra, Vincenzina / Morretta, Chiara / Moschese, Davide / Murace, Celeste Ambra / Murdolo, Martina / Murri, Rita / Napoli, Marco / Nardella, Elisabetta / Natalello, Gerlando / Natalini, Daniele / Navarra, Simone Maria / Nesci, Antonio / Nicoletti, Alberto / Nicoletti, Rocco / Nicoletti, Tommaso Filippo / Nicolò, Rebecca / Nicolotti, Nicola / Nista, Enrico Celestino / Nuzzo, Eugenia / Oggiano, Marco / Ojetti, Veronica / Pagano, Francesco Cosimo / Paiano, Gianfranco / Pais, Cristina / Pallavicini, Federico / Palombo, Andrea / Paolillo, Federico / Papa, Alfredo / Papanice, Domenico / Papparella, Luigi Giovanni / Paratore, Mattia / Parrinello, Giuseppe / Pasciuto, Giuliana / Pasculli, Pierpaolo / Pecorini, Giovanni / Perniola, Simone / Pero, Erika / Petricca, Luca / Petrucci, Martina / Picarelli, Chiara / Piccioni, Andrea / Piccolo, Annalisa / Piervincenzi, Edoardo / Pignataro, Giulia / Pignataro, Raffaele / Pintaudi, Gabriele / Pisapia, Luca / Pizzoferrato, Marco / Pizzolante, Fabrizio / Pola, Roberto / Policola, Caterina / Pompili, Maurizio / Pontecorvi, Flavia / Pontecorvi, Valerio / Ponziani, Francesca / Popolla, Valentina / Porceddu, Enrica / Porfidia, Angelo / Porro, Lucia Maria / Potenza, Annalisa / Pozzana, Francesca / Privitera, Giuseppe / Pugliese, Daniela / Pulcini, Gabriele / Racco, Simona / Raffaelli, Francesca / Ramunno, Vittoria / Rapaccini, Gian Ludovico / Richeldi, Luca / Rinninella, Emanuele / Rocchi, Sara / Romanò, Bruno / Romano, Stefano / Rosa, Federico / Rossi, Laura / Rossi, Raimondo / Rossini, Enrica / Rota, Elisabetta / Rovedi, Fabiana / Rubino, Carlotta / Rumi, Gabriele / Russo, Andrea / Sabia, Luca / Salerno, Andrea / Salini, Sara / Salvatore, Lucia / Samori, Dehara / Sandroni, Claudio / Sanguinetti, Maurizio / Santarelli, Luca / Santini, Paolo / Santolamazza, Danilo / Santoliquido, Angelo / Santopaolo, Francesco / Santoro, Michele Cosimo / Sardeo, Francesco / Sarnari, Caterina / Saviano, Angela / Saviano, Luisa / Scaldaferri, Franco / Scarascia, Roberta / Schepis, Tommaso / Schiavello, Francesca / Scoppettuolo, Giancarlo / Sedda, Davide / Sessa, Flaminio / Sestito, Luisa / Settanni, Carlo / Siciliano, Matteo / Siciliano, Valentina / Sicuranza, Rossella / Simeoni, Benedetta / Simonetti, Jacopo / Smargiassi, Andrea / Soave, Paolo Maurizio / Sonnino, Chiara / Staiti, Domenico / Stella, Claudia / Stella, Leonardo / Stival, Eleonora / Taddei, Eleonora / Talerico, Rossella / Tamburello, Elio / Tamburrini, Enrica / Tanzarella, Eloisa Sofia / Tarascio, Elena / Tarli, Claudia / Tersali, Alessandra / Tilli, Pietro / Timpano, Jacopo / Torelli, Enrico / Torrini, Flavia / Tosato, Matteo / Tosoni, Alberto / Tricoli, Luca / Tritto, Marcello / Tumbarello, Mario / Tummolo, Anita Maria / Vallecoccia, Maria Sole / Valletta, Federico / Varone, Francesco / Vassalli, Francesco / Ventura, Giulio / Verardi, Lucrezia / Vetrone, Lorenzo / Vetrugno, Giuseppe / Visconti, Elena / Visconti, Felicia / Viviani, Andrea / Zaccaria, Raffaella / Zaccone, Carmelina / Zelano, Lorenzo / Zileri Dal Verme, Lorenzo / Zuccalà, Giuseppe

    European Journal of Neurology ; ISSN 1351-5101 1468-1331

    2020  

    Keywords Neurology ; Clinical Neurology ; covid19
    Language English
    Publisher Wiley
    Publishing country us
    Document type Article ; Online
    DOI 10.1111/ene.14444
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top